|
× |
|
Changes in Adverse Events Reported by Patients During 6 Months of Fluoxetine Therapy PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Insertion of Foreign Bodies (polyembolokoilamania): Underpinnings and Management Strategies PDF |
$40.00 |
|
$40.00 |
|
× |
|
Metabolic Health of People Admitted to a Psychiatric Intensive Care Unit in Adelaide, South Australia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Quality Indicators in Community Mental Health Services: A Scoping Review PDF |
$40.00 |
|
$40.00 |
|
× |
|
Cognitive-Behavioral Therapy for Psychiatric Comorbidity in a Case of Muscle-Specific Kinase-Positive Myasthenia Gravis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Escitalopram in the Treatment of Panic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Risk of Cardiovascular Diseases and Stroke Events in Methamphetamine Users: A 10-Year Follow-Up Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Best Practices for Starting Clozapine in Patients With Schizophrenia: How to Switch From the Prior Antipsychotic(s) PDF |
$40.00 |
|
$40.00 |
|
× |
|
Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Comorbid Symptom Severity in Attention-Deficit/Hyperactivity Disorder: A Clinical Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Metronidazole-Induced Leukoencephalopathy Presenting as Catatonia PDF |
$40.00 |
|
$40.00 |
|
× |
|
An Open-Label, Flexible-Dose Study of Olanzapine in the Treatment of Trichotillomania PDF |
$40.00 |
|
$40.00 |
|
× |
|
Response to Burn Pit Exposures and COVID-19 PDF |
$40.00 |
|
$40.00 |
|
× |
|
Negative Rumor: Contagion of a Psychiatric Department PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Threat of Behavioral Changes in Dementia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Diagnostic Challenges in Distinguishing Huntington Disease From Tardive Dyskinesia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Toward Targeted ECT: The Interdependence of Predictors of Treatment Response in Depression Further Explained PDF |
$40.00 |
|
$40.00 |
|
× |
|
Engagement PDF |
$40.00 |
|
$40.00 |
|
|